sodium fluoride has been researched along with Bone Diseases, Metabolic in 15 studies
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Because osteopenia increases morbidity of primary biliary cirrhosis (PBC), the effects of cyclical etidronate vs." | 9.08 | Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. ( Alvarez, L; de Osaba, MJ; Guañabens, N; Monegal, A; Parés, A; Peris, P; Pons, F; Roca, M; Rodés, J; Torra, M, 1997) |
| "Because osteopenia increases morbidity of primary biliary cirrhosis (PBC), the effects of cyclical etidronate vs." | 5.08 | Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. ( Alvarez, L; de Osaba, MJ; Guañabens, N; Monegal, A; Parés, A; Peris, P; Pons, F; Roca, M; Rodés, J; Torra, M, 1997) |
| " A random-effects model within a Bayesian framework was applied to compare treatment effects as standardized mean difference (SMD) with their corresponding 95% credible interval (CrI), while odds ratio (OR) was applied to compare adverse events with 95% CrI." | 2.55 | Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease: A systematic review with network meta-analysis. ( Chen, H; Ma, H; Ma, J; Wang, P; Zhang, H; Zhang, Y; Zhao, X; Zhou, C; Zhu, Y, 2017) |
| " The results indicate that supplementation of the mouse drinking water with calcium salts prevents bone changes induced by short-term suspension, while calcium salts in combination with fluoride are less effective as fluoride dosage increases." | 1.28 | Effect of oral calcium and calcium + fluoride treatments on mouse bone properties during suspension. ( Allen, KA; Luttges, MW; Simske, SJ, 1992) |
| "Sodium fluoride (NaF) was administered to 3-month-old ovariectomized rats 1 day after ovariectomy (OVX) for 1, 3, and 6 months." | 1.28 | Effect of fluoride on bone and bone cells in ovariectomized rats. ( Bannié, F; Feuga, M; Marie, PJ; Miravet, L; Modrowski, D, 1992) |
| " BGP was determined before and after administering sodium fluoride at a dosage of 50 mg/day/15 days to three groups: 14 patients with insulin-dependent diabetes, 16 diabetics on oral antidiabetic treatment, and 25 controls, all of similar age, sex, and characteristics." | 1.28 | Suggestion of a deficient osteoblastic function in diabetes mellitus: the possible cause of osteopenia in diabetics. ( Cabranes, JA; Gomez-Castresana, F; Hernandez, ER; Rico, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Park, PSU | 1 |
| Raynor, WY | 1 |
| Sun, Y | 1 |
| Werner, TJ | 1 |
| Rajapakse, CS | 1 |
| Alavi, A | 1 |
| Luu, AN | 1 |
| Anez-Bustillos, L | 1 |
| Aran, S | 1 |
| Araiza Arroyo, FJ | 1 |
| Entezari, V | 1 |
| Rosso, C | 1 |
| Snyder, BD | 1 |
| Nazarian, A | 1 |
| Zhao, X | 1 |
| Zhou, C | 1 |
| Chen, H | 1 |
| Ma, J | 1 |
| Zhu, Y | 1 |
| Wang, P | 1 |
| Zhang, Y | 1 |
| Ma, H | 1 |
| Zhang, H | 1 |
| Gruber, HE | 1 |
| Brautbar, N | 1 |
| Søgaard, CH | 1 |
| Mosekilde, L | 1 |
| Thomsen, JS | 1 |
| Richards, A | 1 |
| McOsker, JE | 1 |
| Guañabens, N | 1 |
| Parés, A | 1 |
| Monegal, A | 1 |
| Peris, P | 1 |
| Pons, F | 1 |
| Alvarez, L | 1 |
| de Osaba, MJ | 1 |
| Roca, M | 1 |
| Torra, M | 1 |
| Rodés, J | 1 |
| Rouillard, S | 1 |
| Lane, NE | 1 |
| Simske, SJ | 1 |
| Luttges, MW | 1 |
| Allen, KA | 1 |
| Modrowski, D | 1 |
| Miravet, L | 1 |
| Feuga, M | 1 |
| Bannié, F | 1 |
| Marie, PJ | 1 |
| Treves, R | 1 |
| Harang, H | 1 |
| Bertin, P | 1 |
| Bonnet, C | 1 |
| Arnaud, M | 1 |
| Desproges-Gotteron, R | 1 |
| Rico, H | 2 |
| Cabranes, JA | 2 |
| Hernandez, ER | 2 |
| Barabash, A | 1 |
| Romero, P | 1 |
| Kidder, LS | 1 |
| Klein, GL | 1 |
| Stuart, CA | 1 |
| Lee, TC | 1 |
| Gundberg, CM | 1 |
| Alcock, N | 1 |
| Cooper, CW | 1 |
| Simmons, DJ | 1 |
| Bar-Shira-Maymon, B | 1 |
| Coleman, R | 1 |
| Steinhagen-Thiessen, E | 1 |
| Silbermann, M | 1 |
| Gomez-Castresana, F | 1 |
| Lane, JM | 1 |
| Werntz, JR | 1 |
| Healey, JH | 1 |
| Vigorita, VJ | 1 |
4 reviews available for sodium fluoride and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Topics: Animals; Autoimmune Diseases; Biomarkers; Bone Diseases; Bone Diseases, Metabolic; Diagnosis, Differ | 2021 |
Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease: A systematic review with network meta-analysis.
Topics: Alendronate; Bayes Theorem; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic | 2017 |
Hepatic osteodystrophy.
Topics: Bone Diseases, Metabolic; Calcitonin; Chronic Disease; Diphosphonates; Hormone Replacement Therapy; | 2001 |
Metabolic bone disease and Paget's disease in the elderly. Part I: Metabolic bone disease.
Topics: Aged; Bone and Bones; Bone Development; Bone Diseases, Metabolic; Calcium; Estrogens; Female; Humans | 1986 |
2 trials available for sodium fluoride and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years.
Topics: Absorptiometry, Photon; Bone Density; Bone Diseases, Metabolic; Drug Administration Schedule; Etidro | 1997 |
Reversion of the steroid-induced decrease of serum osteocalcin with sodium fluoride.
Topics: Adrenal Cortex Hormones; Bone Diseases, Metabolic; Female; Humans; Male; Middle Aged; Osteocalcin; S | 1991 |
9 other studies available for sodium fluoride and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Microstructural, densitometric and metabolic variations in bones from rats with normal or altered skeletal states.
Topics: Absorptiometry, Photon; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Female; Flu | 2013 |
Metabolic bone disease and the elderly: current approach to diagnosis and therapy.
Topics: Age Factors; Aged; Anabolic Agents; Bone and Bones; Bone Diseases, Metabolic; Bone Resorption; Calci | 1984 |
A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model.
Topics: Animals; Biomechanical Phenomena; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Female; Fe | 1997 |
Effect of oral calcium and calcium + fluoride treatments on mouse bone properties during suspension.
Topics: Animals; Biomechanical Phenomena; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Resor | 1992 |
Effect of fluoride on bone and bone cells in ovariectomized rats.
Topics: Alkaline Phosphatase; Animals; Body Weight; Bone and Bones; Bone Diseases, Metabolic; Calcium; Cell | 1992 |
Adolescent osteoporosis disclosing familial osteopenia.
Topics: Adolescent; Bone Density; Bone Diseases, Metabolic; Calcifediol; Calcium Carbonate; Drug Therapy, Co | 1992 |
Skeletal effects of sodium fluoride during hypokinesia.
Topics: Animals; Bone and Bones; Bone Diseases, Metabolic; Bone Resorption; Kinesis; Male; Osteocalcin; Rats | 1990 |
Correlation between alkaline and acid phosphatase activities and age-related osteopenia in murine vertebrae.
Topics: Acid Phosphatase; Aging; Alkaline Phosphatase; Animals; Bone Diseases, Metabolic; Female; Histocytoc | 1989 |
Suggestion of a deficient osteoblastic function in diabetes mellitus: the possible cause of osteopenia in diabetics.
Topics: Bone and Bones; Bone Diseases, Metabolic; Calcium-Binding Proteins; Diabetes Mellitus, Type 1; Diabe | 1989 |